Multipathogen adoptive immunotherapy for post-transplant virus-associated diseases [ 2016 - ]

Research Grant

Researchers: Prof Rajiv Khanna (Principal investigator) ,  A/Pr Corey Smith ,  A/Pr Scott Campbell ,  Prof Daniel Chambers

Brief description This project is aiming to develop an “off-the-shelf” killer T cell therapy for transplant patients and patients with virus-associated malignancies. This therapy is based on a novel technology developed by our group which allows rapid expansion of killer T cells directed against multiple viruses.

Funding Amount $1,074,188.00

Funding Scheme Project Grants

Notes Standard Project Grant